Mativ Holdings, Inc. (NYSE:MATV – Get Free Report) was the recipient of some unusual options trading activity on Friday. Investors bought 3,998 call options on the stock. This represents an increase of 84% compared to the typical daily volume of 2,168 call options.
Wall Street Analyst Weigh In
Separately, Stifel Nicolaus initiated coverage on shares of Mativ in a research report on Thursday, November 21st. They set a “hold” rating and a $15.50 price objective on the stock.
Read Our Latest Report on Mativ
Hedge Funds Weigh In On Mativ
Mativ Stock Performance
Shares of NYSE MATV opened at $11.95 on Friday. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.29 and a current ratio of 2.37. The company has a market cap of $649.32 million, a P/E ratio of 6.10, a P/E/G ratio of 3.29 and a beta of 0.64. The firm’s fifty day moving average is $14.32 and its two-hundred day moving average is $16.33. Mativ has a 52-week low of $10.78 and a 52-week high of $19.96.
Mativ Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Friday, November 29th will be paid a $0.10 dividend. The ex-dividend date is Friday, November 29th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 3.35%. Mativ’s payout ratio is currently 20.41%.
About Mativ
Mativ Holdings, Inc, together with its subsidiaries, manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally. The company operates through two segments, Advanced Technical Materials and Fiber-Based Solutions. The Advanced Technical Materials manufactures and sells various engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, protective solutions, release liners, and healthcare end-markets.
Read More
- Five stocks we like better than Mativ
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- With Risk Tolerance, One Size Does Not Fit All
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is the FTSE 100 index?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Mativ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mativ and related companies with MarketBeat.com's FREE daily email newsletter.